Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Traumatic Brain Injury
NCT06262061Phase 1Not yet recruiting
- Sponsor
- London Health Sciences Centre
- Start
- Mar 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of propranolol in traumatic brain injury (TBI) (2 arms), sponsored by London Health Sciences Centre. Primary endpoints: Hospital Mortality at 1 month and Cognitive Function at 6 months. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06262061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06262061.